Patient-provider communication about the use of medical cannabis for cancer symptoms: a cross-sectional study
Overall, our study suggests that patient-provider communication about medical cannabis for cancer symptom management is limited. As interest and use of medical cannabis continues to grow among cancer patients, there is a need to ensure patients have access to high quality patient-provider communication.
Authors
- Brian D. Gonzalez (ORCID: https://orcid.org/0000-0001-5108-5735)
- Sahana Rajasekhara (ORCID: https://orcid.org/0000-0003-3877-6165)
- Kea L. Turner (ORCID: https://orcid.org/0000-0002-7885-0879)
- Jessica Y. Islam (ORCID: https://orcid.org/0000-0002-3690-3848)
- Kathleen M. Egan (ORCID: https://orcid.org/0000-0001-8772-6979)
- Oliver T. Nguyen (ORCID: https://orcid.org/0000-0003-2852-7106)
- Heather S.L. Jim (ORCID: https://orcid.org/0000-0001-7353-3711)
- Amir Alishahi Tabriz (ORCID: https://orcid.org/0000-0002-6273-9105)
- Yessica C. Martinez
Institutions
- University of South Florida (US)
- Moffitt Cancer Center (US)
Publication Details
- Journal
- JNCI Monographs
- Published
- 2024-08-01
- DOI
- https://doi.org/10.1093/jncimonographs/lgad026
- Citations
- 2
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 0.90
Funders
- American Association for Cancer Research
- Moffitt Cancer Center
- National Institutes of Health
- National Cancer Institute